Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical study of AB011 in Combination with atezolizumab with standard-of-care chemotherapy in patients with gastric or gastroesophageal junction carcinoma

Next Previous
Trial Profile

Clinical study of AB011 in Combination with atezolizumab with standard-of-care chemotherapy in patients with gastric or gastroesophageal junction carcinoma

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 10 May 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AB 011 (Primary) ; Atezolizumab (Primary) ; Capecitabine; Oxaliplatin
  • Indications Carcinoma; Gastric cancer; Oesophageal cancer
  • Focus Therapeutic Use

Most Recent Events

  • 05 May 2023 According to a CARsgen media release, AB011 in combination with atezolizumab received IND clearance from NMPA for first-line treatment Claudin18.2 (CLDN18.2) positive unresectable locally advanced, recurrent or metastatic gastric cancer/gastroesophageal junction cancer.
  • 03 Feb 2023 New trial record
  • 31 Jan 2023 According to a CARsgen media release, trial will be conducted as part of Roche's Morpheus Platform.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top